Metformin remains the logical first line drug for type 2 diabetesBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7581.1265-c (Published 14 December 2006) Cite this as: BMJ 2006;333:1265
In people with type 2 diabetes, the relatively new drug rosiglitazone was significantly better at lowering blood glucose than metformin or glyburide. But at least one independent expert says metformin should remain the recommended first line treatment (pp 2477-80). Why?
Rosiglitazone significantly …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial